ScholarIQanswers from OpenAlex
Adaptive Randomization of Neratinib in Early Breast Cancer
PaperCitations, authors & open-access status
Adaptive Randomization of Neratinib in Early Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Adaptive Randomization of Neratinib in Early Breast Cancer have?
ScholarIQcitation count
Adaptive Randomization of Neratinib in Early Breast Cancer has 465 citations in the OpenAlex counts ScholarIQ stores.
When was Adaptive Randomization of Neratinib in Early Breast Cancer published?
ScholarIQyear
Adaptive Randomization of Neratinib in Early Breast Cancer has 2016 year in the ScholarIQ index.
What is the open-access status of Adaptive Randomization of Neratinib in Early Breast Cancer?
ScholarIQoa status
Adaptive Randomization of Neratinib in Early Breast Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Adaptive Randomization of Neratinib in Early Breast Cancer?
ScholarIQdoi
The DOI for Adaptive Randomization of Neratinib in Early Breast Cancer is on the source record.
What is the PMID of Adaptive Randomization of Neratinib in Early Breast Cancer?
ScholarIQpmid
The PMID for Adaptive Randomization of Neratinib in Early Breast Cancer is on the source record.
What is the OpenAlex record for Adaptive Randomization of Neratinib in Early Breast Cancer?
ScholarIQopenalex
The OpenAlex for Adaptive Randomization of Neratinib in Early Breast Cancer is on the source record.